Skip to main content
Solid Tumor Genitourinary Cancer

Genitourinary Cancer

18-04-2024 Kidney Cancer News

Postoperative pembrolizumab improves OS in high-risk RCC

Adjuvant treatment with pembrolizumab is associated with a significant survival benefit in individuals with high-risk renal cell carcinoma.

ADCs in cancer: key data for currently approved agents

Open Access Cancer Therapy Review

Delve into the efficacy and safety data for the antibody–drug conjugates currently approved by the US FDA across tumor types such as hematologic, genitourinary, and gynecologic cancers.

Three-phase screening approach promising for prostate cancer

11-04-2024 Prostate Cancer News

The ProScreen trial points to the potential of a single round of prostate cancer screening involving a PSA test, a kallikrein panel, and an MRI scan.

Lymph node dissection in testicular cancer

Open Access Testicular Cancer Review

Retroperitoneal lymph node dissection is a valuable tool in the management of testicular cancer. Gain an understanding of its key role in diagnosis and staging, and beyond.

Exercise may serve as a painkiller for cancer survivors

Being physically active could help to reduce the intensity of pain experienced by people with a history of cancer.

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine

Case-Based Insights: Oncology and Hematology (Link opens in a new window)


Refresh your knowledge in Oncology and Hematology: 

  • 45 clinical cases across different topics with relevant clinical images
  • Written by renowned experts 
  • Knowledge-check questions with answers
Try the first set of cases now

Current Reviews

Biparametric MRI in prostate cancer during active surveillance: is it safe?

Open Access Prostate Cancer Invited Review

Active surveillance (AS) is a strategy recommended by the European Association of Urology (EAU) for patients presenting with low or favourable intermediate-risk prostate cancer (PCa) [ 1 ]. AS involves identifying optimal timings for curative …

Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape

With the age of monoclonal antibodies (mabs) ushered in by Köhler and Milstein’s 1975 breakthrough in hybridoma technology, there came potential for developing specific, targeted cancer therapeutics. One of the most significant has been …

Protein intake and cancer: an umbrella review of systematic reviews for the evidence-based guideline of the German Nutrition Society

Open Access Prostate Cancer Review

The global incidence of cancer is on the increase. It is expected that cancer will become the most frequent cause of death in most countries worldwide during the twenty-first century [ 1 , 2 ]. Despite advances in early detection and treatment …

Psychosocial Factors Associated with Cognitive Function in Prostate Cancer Survivors on Hormonal Treatments: A Systematic Review

Open Access Prostate Cancer Review

Hormonal treatments (HT) for prostate cancer (e.g., androgen deprivation therapy) yield clinical and survival benefits, yet adverse cognitive changes may be a side effect. Since psychosocial factors are largely modifiable, interventions targeting …

Webinar | 16-05-2023 | 17:30 (CEST)

Keynote webinar | Spotlight on cardio-oncology

An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.

Prof. Rudolf de Boer
Prof. Lorenz Lehmann
Dr. Teresa Lopéz Fernández
Developed by: Springer Medicine

Case Studies

Lung erosion following adjuvant immunotherapy

Open Access Pneumothorax Case Study

Adjuvant pembrolizumab treatment after resection of lung metastases in a patient with renal cell carcinoma may have led to lung erosion that resulted in a pneumothorax.

Progressive encephalomyelitis with rigidity and myoclonus (PERM) associated with urothelial carcinoma

The first reported case of PERM associated with anti-glycine receptor antibodies in a patient with bladder cancer. PERM, a stiff-person syndrome, has paraneoplastic etiology in about 20% of cases.

eLearning | Interviews | Cases (Link opens in a new window)

Multiformat program highlighting evidence-based best practice for the management of metastatic urothelial carcinoma.

Supported by:
  • Pfizer and Merck Healthcare KGaA, Darmstadt, Germany
Developed by: Springer Healthcare IME

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Further Reading

Biparametric MRI in prostate cancer during active surveillance: is it safe?

Open Access Prostate Cancer Invited Review

Active surveillance (AS) is a strategy recommended by the European Association of Urology (EAU) for patients presenting with low or favourable intermediate-risk prostate cancer (PCa) [ 1 ]. AS involves identifying optimal timings for curative …

Long-term quality of life of testicular cancer survivors differs according to applied adjuvant treatment and tumour type

Open Access Radiotherapy

Testicular cancer (TC) is the most common solid malignancy in young men, with rising incidence rates [ 1 ]. As the disease has an excellent cure rate and affects mostly young men, TC survivors bear a significant risk of suffering from long-term …

Cancer-Related Health and Educational Needs and Faith-Based Health Beliefs in an Urban Muslim Population

Cancer screening behaviors in Muslims are under-researched, and there is limited data on how it relates to their unique cultural and religious beliefs. We assessed cancer prevention and screening-related health needs in the Washington DC area. We …

Protein intake and cancer: an umbrella review of systematic reviews for the evidence-based guideline of the German Nutrition Society

Open Access Prostate Cancer Review

The global incidence of cancer is on the increase. It is expected that cancer will become the most frequent cause of death in most countries worldwide during the twenty-first century [ 1 , 2 ]. Despite advances in early detection and treatment …